Transcriptomics

Dataset Information

0

Effect of Bacteroides fragilis administration on microglia in WT and the APP-PS1 model of Alzheimer's disease [Bfrag]


ABSTRACT: The gut microbiota and innate immune system play critical roles in Alzheimer’s disease (AD). Bacteroides is elevated in AD patients and correlates with cerebrospinal fluid levels of Aβ and tau. We found that increased amyloid-β (Aβ) plaques in Bacteroides fragilis treated APP/PS1-21 mice were associated with altered cortical expression Aβ processing genes. B. fragilis suppressed peripheral CD4+ T cell production of GM-CSF and IL-4 and transcriptional changes in microglia related to GM-CSF and IL-4 signaling, phagocytosis, and protein degradation. Furthermore, B. fragilis impaired the microglial uptake of intracranially injected Aβ42, whereas Erysipelotrichaceae strains increased uptake. Depleting murine Bacteroidetes with metronidazole decreased amyloid load in aged 5xFAD mice, increased CD4+ T cell GM-CSF production, and activated microglial pathways related to cytokine signaling, phagocytosis and lysosomal degradation. These data suggest that the gut microbiome may contribute to AD pathogenesis by suppressing peripheral cytokines and microglia phagocytic function, leading to impaired immune-mediated Aβ clearance.

ORGANISM(S): Mus musculus

PROVIDER: GSE215438 | GEO | 2024/10/12

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-10-12 | GSE215439 | GEO
2024-02-29 | GSE255034 | GEO
2020-07-15 | GSE154428 | GEO
2023-07-18 | GSE208006 | GEO
2023-02-01 | GSE191118 | GEO
2020-05-01 | GSE147495 | GEO
2023-01-09 | PXD038665 | Pride
2022-07-04 | GSE206202 | GEO
2018-12-19 | GSE122438 | GEO
2024-09-30 | GSE235179 | GEO